Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | KLK7 | P49862 | 1/20 | 0.44 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.41 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2848265 | 0.80 | KLK5 (0.64) | KLK7KLK5CASP3 | |
| SCHEMBL2841932 | 0.80 | KLK7 (0.45) | HDAC1HDAC2KLK7KLK5CASP3 | |
| SCHEMBL2849324 | 0.79 | PTGER4 (0.47) | KLK7KLK5CASP3PTGER4SIRT5 | |
| Hydrochloric Acid SCHEMBL2845461 | 0.79 | KLK7 (0.44) | HDAC1HDAC2KLK7KLK5CASP3 | |
| SCHEMBL2840270 | 0.78 | CTSB (0.42) | ANPEPHDAC1HDAC2KLK7KLK5 | |
| SCHEMBL2843551 | 0.78 | PTGER4 (0.46) | KLK7KLK5CASP3PTGER4 | |
| SCHEMBL2842792 | 0.78 | HDAC1 (0.49) | HDAC1KLK7KLK5CASP3PTGER4 | |
| Hydrochloric Acid SCHEMBL2846241 | 0.77 | HDAC1 (0.43) | ANPEPHDAC1HDAC2KLK7KLK5 | |
| SCHEMBL2841689 | 0.77 | KLK7 (0.43) | KLK7KLK5CASP3ALDH1A1CYP1A2 | |
| SCHEMBL2842784 | 0.77 | SIRT5 (0.47) | HDAC1HDAC2KLK7KLK5CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100216803-A1 | ORNITHINE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2141147-A1 | ORNITHINE DERIVATIVE | Astellas Pharma Inc. (JP) | 2010-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216803-A1 | ORNITHINE DERIVATIVE | PTGER4, OXER1, ODC1 | ANPEP 878/4885HDAC1 3656/4885HDAC2 1494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.